Keith Al-Hasani

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Dna Methylation

Glycemic Control

Dendritic Cells

Top Venues

Signal transduction and targeted therapy

Clinical epigenetics

Cellular and molecular life sciences : CMLS

NPJ Regenerative medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Keith Al-Hasani, Ishant Khurana, Lina Mariana, Thomas Loudovaris, Scott Maxwell, K N Harikrishnan, Jun Okabe, Mark E Cooper, Assam El-Osta
Inhibition of pancreatic EZH2 restores progenitor insulin in T1D donor. Signal transduction and targeted therapy 7 (1) (2022)
Safiya Naina Marikar, Assam El-Osta, Angus Johnston, Georgina Such, Keith Al-Hasani
Microencapsulation-based cell therapies. Cellular and molecular life sciences : CMLS 79 (7) (2022)
Ishant Khurana, Scott Maxwell, Simon G Royce, Prabhu Mathiyalagan, Tom C Karagiannis, Nadia Mazarakis, Jitraporn Pimm Vongsvivut, Harikrishnan Kaipananickal, Jun Okabe, Keith Al-Hasani, Chrishan S Samuel, Assam El-Osta
SAHA attenuates Takotsubo-like myocardial injury by targeting an epigenetic Ac/Dc axis. Signal transduction and targeted therapy 6 (1) (2021)
Sebastian Lunke, Scott Maxwell, Ishant Khurana, Harikrishnan Kaipananickal, Jun Okabe, Keith Al-Hasani, Assam El-Osta
Epigenetic evidence of an Ac/Dc axis by VPA and SAHA. Clinical epigenetics 13 (1) (2021)
Ishant Khurana, Keith Al-Hasani, Scott Maxwell, Harikrishnan K N, Jun Okabe, Mark E Cooper, Patrick Collombat, Assam El-Osta
DNA methylation status correlates with adult β-cell regeneration capacity. NPJ Regenerative medicine 6 (1) (2021)